健康・医薬品プレスリリース

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China Dec 15, 2025 21:00 JST More info..

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China Dec 15, 2025 21:00 JST More info..

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China Dec 15, 2025 21:00 JST More info..

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China Dec 15, 2025 21:00 JST More info..

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China Dec 11, 2025 21:00 JST More info..

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China Dec 11, 2025 21:00 JST More info..

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China Dec 11, 2025 21:00 JST More info..

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China Dec 11, 2025 21:00 JST More info..

エーザイ、CDP より「気候変動」「水セキュリティ」分野で最高評価 A リストに 2 年連続でダブル選定
Dec 11, 2025 11:50 JST

エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、国際的な環境非営利団体 CDP1より 2025 年の「気候変動」および「水セキュリティ」分野において、最高評価である A リストに選定されましたのでお知らせします。2 年連続での両分野における A リストへのダブル選定となります。
More info..

AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation
Dec 02, 2025 22:18 JST

AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from Korea, together with their Malaysian subsidiary, AdipoLABs Healthcare (M) Sdn Bhd, today officially opened the new AdipoLABs regional office for Asia-Pacific, marking a strategic expansion to strengthen its leadership in non- invasive healthcare and build a robust MedTech ecosystem in Malaysia and across ASEAN.
More info..

業種

健康・医薬品 プレスリリース

健康・医薬品プレスリリース